Wasatch Advisors’s BioLife Solutions BLFS Stock Holding History

Wasatch Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-477,463	Closed	-$20.2M	–	262
2021 Q3	$20.2M	Sell	477,463 -648,803	-58%	-$31.2M	0.08%	173
2021 Q2	$50.1M	Sell	1,126,266 -6,205	-0.5%	-$219K	0.2%	108
2021 Q1	$40.8M	Sell	1,132,471 -203,774	-15%	-$8.06M	0.18%	104
2020 Q4	$53.3M	Sell	1,336,245 -380,670	-22%	-$13M	0.26%	91
2020 Q3	$49.7M	Buy	+1,716,915	New	+$37.1M	0.32%	92

Other funds holding BLFS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wasatch Advisors's BLFS Position: Q4 2021 in Review

Wasatch Advisors sold out of BioLife Solutions (BLFS) in Q4 2021, closing a stake of 477,463 shares — an estimated $20.2M sold.

Wasatch Advisors first reported a position in BLFS in Q3 2020 and held it in 5 quarters. The position peaked at $53.3M in Q4 2020. 169 funds tracked by Wall St. Rank hold BLFS as of Q4 2021.

Wasatch Advisors reported no remaining BioLife Solutions position as of Q4 2021 after selling out during the quarter.
Wasatch Advisors sold 477,463 BioLife Solutions shares in Q4 2021, an estimated $20.2M.
Wasatch Advisors first reported a position in BioLife Solutions in Q3 2020 and held it in 5 quarters.
Wasatch Advisors's BioLife Solutions position peaked at $53.3M in Q4 2020.
169 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2021.

Based on Wasatch Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.